ESCRS - PO445 - First Results Of Relex Smile Pro With The New Visumax 800

First Results Of Relex Smile Pro With The New Visumax 800

Published 2022 - 40th Congress of the ESCRS

Reference: PO445 | Type: Free paper | DOI: 10.82333/ybr1-zb48

Authors: Detlev Breyer* 1 , Hakan Kaymak 1 , Karsten Klabe 1 , Mücella Kirca 2 , Lena Beckers 3 , Florian Kretz 4 , Gerd Auffarth 5

1Breyer-Kaymak-Klabe Eye Surgery & premium Eyes,Düsseldorf,Germany;Internationale Innovative Ophthalmochirurgie,Düsseldorf,Germany;International Vision Correction Research Center Network (IVCRC.net),Heidelberg,Germany, 2Internationale Innovative Ophthalmochirurgie,Düsseldorf,Germany, 3Breyer-Kaymak-Klabe Eye Surgery & premium Eyes,Düsseldorf,Germany, 4Augentagesklinik Rheine,Rheine,Germany;International Vision Correction Research Center Network (IVCRC.net),Rheine,Germany, 5Augenklinik, Universitätsklinikum Heidelberg, ,Heidelberg,Germany;International Vision Correction Research Center Network (IVCRC.net),Heidelberg,Germany

Purpose

The aim of this retrospective quality management investigation was to evaluate the first visual outcomes for ReLEx Smile Pro using the Visumax 800 regarding safety, predictability and efficacy.

Setting

All surgeries were performed by one surgeon at the Breyer-Kaymak-Klabe Eye Surgery and Premium Eyes in Duesseldorf, Germany, member of the International Vision Correction Research Center (IVCRC.net).

Methods

Results of 300 eyes underwent the ReLEx SMILE Pro procedure using the Visumax 800 Femtosecond Laser from ZEISS to correct myopia. The follow up was performed after three months postoperatively to evaluate safety, predictability and efficacy.

Results

Data will be presented at the ESCRS 2022 in Milano.

Conclusions

First clinical results after one month are very similar to the published data from Visumax 500. Three months results are expected due to neuroadaptation.